Patent classifications
C07C275/38
BENZAMIDE DERIVATIVE
The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R.sub.1, Z and Q are as described in the description.
##STR00001##
BENZAMIDE DERIVATIVE
The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R.sub.1, Z and Q are as described in the description.
##STR00001##
N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
Compositions and methods for inhibiting translation initiation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using N,N-diarylureas and/or N,N-diarylthiourea compounds are described.
N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
Compositions and methods for inhibiting translation initiation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using N,N-diarylureas and/or N,N-diarylthiourea compounds are described.
Urea motif containing compounds and derivatives thereof as antibacterial drugs
The invention relates to compounds which are suitable for treating bacterial diseases and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of parts comprising such compounds and to the use of such compounds as disinfectants.
Urea motif containing compounds and derivatives thereof as antibacterial drugs
The invention relates to compounds which are suitable for treating bacterial diseases and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of parts comprising such compounds and to the use of such compounds as disinfectants.
Diarylureas as CB1 allosteric modulators
The present invention provides novel diarylurea derivatives (compounds of formula (I)) and their uses. The compounds of the present invention are demonstrated to be allosteric modulators of the CB1 receptor, and therefore useful for the treatment of diseases and conditions mediated by CB1.
Diarylureas as CB1 allosteric modulators
The present invention provides novel diarylurea derivatives (compounds of formula (I)) and their uses. The compounds of the present invention are demonstrated to be allosteric modulators of the CB1 receptor, and therefore useful for the treatment of diseases and conditions mediated by CB1.